Frederick E. Dewey, MD; Megan E. Grove, MS; Cuiping Pan, PhD; et al.
Dewey and colleagues found that depending on the sequencing platform used, there was incomplete coverage of inherited disease genes, low reproducibility of potentially clinically significant genetic variation, and uncertainty about clinically reportable findings.